GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Inventories, Inventories Adjustments

Incanthera (AQSE:INC) Inventories, Inventories Adjustments : £0.00 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Inventories, Inventories Adjustments?

Incanthera's Inventories, Inventories Adjustments for the quarter that ended in Sep. 2023 was £0.00 Mil.


Incanthera Inventories, Inventories Adjustments Historical Data

The historical data trend for Incanthera's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Inventories, Inventories Adjustments Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Inventories, Inventories Adjustments
- - - -

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Inventories, Inventories Adjustments Get a 7-Day Free Trial - - - - -

Incanthera Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Incanthera (AQSE:INC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Inventories, Inventories Adjustments
Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines